Balchem Corporation  

(Public, NASDAQ:BCPC)   Watch this stock  
Find more results for BCPC
55.62
+0.82 (1.50%)
Jul 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 53.84 - 56.13
52 week 48.89 - 69.92
Open 54.78
Vol / Avg. 130,360.00/173,085.00
Mkt cap 1.70B
P/E 29.45
Div/yield 0.30/0.54
EPS 1.89
Shares 31.09M
Beta 1.00
Inst. own 83%
Aug 4, 2015
Q2 2015 Balchem Corp Earnings Call - 11:00AM EDT - Add to calendar
Jun 17, 2015
Balchem Corp Annual Shareholders Meeting
May 5, 2015
Q1 2015 Balchem Corp Earnings Call
May 5, 2015
Q1 2015 Balchem Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 10.47% 9.76%
Operating margin 17.28% 15.17%
EBITD margin - 20.85%
Return on average assets 7.09% 8.53%
Return on average equity 15.15% 14.61%
Employees 845 -
CDP Score - -

Address

P O Box 600
NEW HAMPTON, NY 10958
United States - Map
+1-845-3265632 (Phone)
+1-845-3265742 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in three segments: Specialty Products, SensoryEffects and Animal Nutrition & Health (ANH). The Company sells its products through its own sales force, independent distributors and sales agents. The Specialty Products segment offers Ethylene oxide, canisters and propylene oxide. The SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, ready-to-eat cereals, grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies-based nutritional products.

Officers and directors

Dino A. Rossi Executive Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Theodore L. Harris President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
William A. Backus CPA Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
David F. Ludwig Vice President, General Manager- Specialty Products, Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Francis J. Fitzpatrick CPA Vice President - Administration
Age: 54
Bio & Compensation  - Reuters
Matthew D. Houston General Counsel, Secretary
Age: 51
Bio & Compensation  - Reuters
John Y. Televantos Ph.D. Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Paul D. Coombs Independent Director
Age: 59
Bio & Compensation  - Reuters
David B. Fischer Independent Director
Age: 52
Bio & Compensation  - Reuters
Edward L. McMillan Independent Director
Age: 69
Bio & Compensation  - Reuters